Consolidated Statements of Cash Flows (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Net income	$ 3,392,000	$ 1,062,000
Adjustments to reconcile net income to net cash provided by operating activities:
Amortization and depreciation	1,572,000	1,564,000
Share based payment expense	159,000	68,000
Deferred income taxes	(2,170,000)	0
Changes in operating assets and liabilities:
(Increase) decrease in accounts receivable	(1,423,000)	1,556,000
(Increase) decrease in prepaid expenses and other current assets	(85,000)	49,000
Increase (decrease) in due to models	1,612,000	(2,507,000)
Increase (decrease) in accounts payable and accrued liabilities	305,000	(921,000)
(Decrease) in foreign withholding claim	(428,000)
(Decrease) in deferred revenues		(540,000)
Net cash provided by operating activities	2,932,000	331,000
Cash flows from investing activities:
Purchase of property and equipment	(421,000)	(102,000)
Net cash used in investing activities	(421,000)	(102,000)
Cash flows from financing activities
Decrease in earnout liability	(20,000)	(1,735,000)
Proceeds from Amegy line of credit	500,000	2,000,000
Repayment of Amegy line of credit	(950,000)	(1,250,000)
Purchases of Treasury Stock	(410,000)	(1,227,000)
Net cash used in financing activities	(880,000)	(2,212,000)
Net increase (decrease) in cash and cash equivalents	1,631,000	(1,983,000)
Cash and cash equivalents, beginning of period	1,145,000	3,128,000
Cash and cash equivalents, end of period	2,776,000	1,145,000
Supplemental disclosures of cash flow information
Cash paid for interest	61,000	44,000
Cash paid for income taxes	$ 346,000	$ 698,000